Full article reprinted from "The Gray Sheet" - August 18, 2008
FDA's device center has seen a lot of jumping around this year, with more than 40 upper-level moves since January (see chart: "New Jobs Since January").
Full article reprinted from "The Gray Sheet" - August 18, 2008
The CDRH Shuffle: Device Center Tweaks Management Personnel
FDA's device center has seen a lot of jumping around this year, with more than 40 upper-level moves since January (see chart: "1New Jobs Since January").
The Office of Device Evaluation (ODE) in June brought in Ginette Michaud from its division of anesthesiology, general hospital, infection control and dental devices to serve as acting clinical deputy director. Michaud replaces Aron Yustein, on detail to the Office of Surveillance and Biometrics since February.
Former Division of Enforcement B deputy director Christy Foreman is the new acting deputy director for engineering and science review at ODE, and Barbara Zimmerman is the acting associate director, replacing Robert Gatling.
Gatling will permanently head up the office's program operations staff, freeing Heather Rosecrans to return to her post as director of the 510(k) section, as of June 8.
Former Office of Compliance staffer Nicole Wolanski replaced Samie Allen May 19 as PMA section director. And in mid-June, Ashley Boam left ODE's central office to return to her spot as chief of the interventional cardiology devices branch within the Division of Cardiovascular Devices.
Meanwhile, the cardiovascular division named Mitchell Shein acting chief of the pacing, defibrillator and leads branch, after Megan Moynahan left in January to lead the Cardiac Electrophysiology and Monitoring Network in the Office of the Center Director, part of CDRH's new cross-center post-market safety "matrix" organization ("The Gray Sheet" July 21, 2008, p. 7).
- Jessica Bylander
Interested in what's happening at CDRH? Keep up with a free trial of "The Gray Sheet"
